Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats

Background The discovery of calcium receptors and calcimimetics created the possibility of “pharmacologic parathyroidectomy” (phPTX), which decreased secretion of parathormone (PTH). Parathyroid glands of spontaneously hypertensive rats (SHR) and of patients with primary hyperparathyroidism and hypertension secrete parathyroid hypertensive factor (PHF). Parathyroidectomy decreases blood pressure in these rats and in patients. The present study determined whether phPTX induced by calcimimetics decreases mean arterial blood pressure (MAP) in hypertensive rats. Methods Hypertensive SHR and normotensive Wistar Kyoto (WKY) rats were used. Clearance experiments were performed and the effect of 1 mg/kg body weight (given intravenously) synthesized NPS R-568 (NPS) on MAP in the presence or absence of thyroparathyroidectomy (TPTX) was monitored. Results The success phPTX and TPTX were proven by a significant decrease in plasma Ca2+ concentration and a decrease in urinary fractional phosphate excretion (FE Pi). The administration of NPS significantly decreased blood pressure in SHR versus SHR/control: Δ(0–50 min of experiment) MAP −16.5 ± 2.5 mm Hg v −3.2 ± 1.5 mm Hg (P< .002). The TPTX decreased blood pressure in SHR versus SHR/control and was not different versus SHR/TPTX/NPS (ΔMAP: −10.2 ± 1.6 mm Hg v −3.2 ± 1.5 mm Hg (P< .01) and v −8.3 ± 2.2 mm Hg (P = not significant). In normotensive WKY rats application of NPS did not reach significance in ΔMAP: −6.7 ± 1.8 mm Hg v −2.6 ± 2.8 mm Hg (P = not significant) in WKY/control. The TPTX lowered blood pressure in WKY versus WKY/control and remained unchanged versus WKY/TPTX/NPS (ΔMAP: −11.3 ± 1.7 mm Hg v −2.6 ± 2.8 mm Hg (P< .04) and v −11.4 ± 2.6 mm Hg (P = not significant). Conclusions We conclude that phPTX with NPS R-568 is responsible for a decrease of MAP in SHR.